Technology Opportunities

BioRap Technologies and the Lipid Research Laboratory of the Rappaport Family Institute are offering collaboration for the identification of antioxidant and anti - atherogenic properties of nutritional antioxidants The lipid research laboratory, headed by Professor Michael Aviram, focuses its ...

Prof. Lior Gepstein's hiPSCs (human induced pluripotent stem cells) approach for modeling inherited cardiac disorders, such as Pompe glycogen storage disease, congenital long QT syndrome type II, CPVT and ARVC, has many implications in cardiovascular regenerative medicine, drug discovery, disease ...

An innovative platform for drug screening, toxicology testing and exploration of nevel means for treating severe cardiac pathologies, has been generated by Prof. Binah, focusing on inherited cardiac diseases such as Long Q-T Syndrome (LQTS), Catecholaminergic Polymorphic Ventricular Tachycardia ...

Professor Gera Neufeld, a member of the Rappaport Family Institute for Research in the Medical Sciences, Haifa, Israel, studies tumor angiogenesis and investigates the molecular mechanisms that contribute to the development and progression of cancer. Vascular endothelial growth factor (VEGF) ...

One of the obstacles in clinical oncology is that tumors sometimes acquire resistance to therapy and spread. Throughout the years, various therapeutic agents have been developed aiming to directly target tumor cells or inhibit tumor-supporting cells in its microenvironment. The development of ...

Optogenetics approaches, utilizing light-sensitive proteins, have emerged as unique experimental paradigms to modulate neuronal excitability and have consequentially revolutionized neuroscience. The group of Dr. Lior Gepstein is developing similar strategies to also control cardiac-tissue ...

The identification of a specific epitope in EMMPRIN that has a role in the induction of both MMP-9 and VEGF, has brought about the development of two novel immunotherapy approached targeting EMMPRIN - A multiple antigenic peptide and a binding antibody. Macrophages heavily infiltrate solid ...

Prof. Youdim, a ground breaking researcher, is listed as an inventor in over 90 patents dealing with neurodegenerative diseases. His research has greatly increased the scientific community's understanding of the processes involved in the development of these diseases and has led to the ...